Alnylam Pharmaceuticals
ALNY
#689
Rank
S$47.90 B
Marketcap
S$358.82
Share price
-1.64%
Change (1 day)
-10.19%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company